AfterPullback: Biotech Stocks

AfterPullback: Biotech Stocks

“AfterPullback: Biotech Stocks” delivers a comprehensive overview of leading U.S.-traded biotech companies, along with emerging and innovative firms that have recently entered the public market. Our selection spans a variety of sectors within biotech, including gene editing, diagnostics, pharmaceuticals, immunotherapy, cancer treatment, regenerative medicine, and bioinformatics.

6 Symbols in watchlist.

Symbol
Price
Change %
Market Cap
Volume
MRNA $33.32 -1.44% $14.18B 6,295,489
PACB $1.95 +5.97% $552.68M 9,118,194
BNTX $104.75 -1.39% $25.54B 719,209
FLGT $23.62 +0.51% $719.31M 128,915
CRSP $67.20 +1.03% $6.05B 1,548,434
ILMN $99.97 +2.81% $14.94B 1,245,594
2025 © AfterPullback LTD

Charts powered by TradingView

Market data may be delayed by 15 minutes or more and is provided by financial exchanges or third-party providers. AfterPullback does not verify or guarantee its accuracy and assumes no responsibility to do so. This website is not operated by a licensed attorney, accountant, or financial advisor. Nothing on this site constitutes financial advice or replaces consultation with a qualified professional who understands your specific circumstances. Always consult a licensed financial advisor before making investment decisions.